Logo_Interreg-Atlantic-Area_COLOR
  • neuroATLANTIC
  • Partners
  • News&Events
  • Contact
  • Results&Outputs
  • twitter
  • linkedin
  • neuroATLANTIC - An Atlantic innovation platform on diagnosis and treatment of neurological diseases and aging - 2

    An Atlantic innovation platform on diagnosis and treatment of neurological diseases and aging

  • neuroATLANTIC - An Atlantic innovation platform on diagnosis and treatment of neurological diseases and aging

    An Atlantic innovation platform on diagnosis and treatment of neurological diseases and aging

  • An Atlantic innovation platform on diagnosis and treatment of neurological diseases and aging

  • An Atlantic innovation platform on diagnosis and treatment of neurological diseases and aging

  • An Atlantic innovation platform on diagnosis and treatment of neurological diseases and aging

What is neuroATLANTIC?

Neurological diseases are disorders that affect the central nervous system and can impair the brain, spinal cord, peripheral nerve or neuromuscular function. Most of these diseases are directly related to ageing, with Alzheimer’s Disease (AD) and stroke being especially relevant due to their incidence and the economic burden they carry. More than 7.5 million European citizens aged between 30 and 99 years suffer from different types of dementia.

neuroATLANTIC project will contribute to address this challenge by proposing new standardized clinical protocols, innovative diagnostic and treatment methods and ensuring technology transfer to enterprises to favour the uptake of innovations in real settings. Specifically, neuroATLANTIC will act on the clinical, preclinical and capitalization aspects as following: 

  1. The project will explore best clinical practices to elaborate a “green paper” to propose an improved clinical management (diagnosis and treatment) of Alzheimer´s Disease and stroke patients. 
  2. neuroATLANTIC will set up a preclinical translational research platform with all the elements needed (animal models, nanostructures synthesis, assessment of exploitation potential, etc.) to bring innovative theragnostic agents and nanobiosensors (to be used to enhance diagnosis and treatment) to real settings. To test the translation platform feasibility, we will focus on two initial projects: biofunciontionalized nanostructures as contrast agents and nanobiosensors. These projects will give us useful insights to strengthen such platform in the future. 
  3. neuroATLANTIC will pay attention to capitalization of results: technology roadmap and exploitation plans will be delivered for the selected projects; a governance structure will be defined in order to select new projects to be developed in the platform and, finally, R&D mission-oriented guidelines will be developed in order to define a strategic R&D agenda to address neurological diseases in the future.

Video Title

News

  • THE GALICIAN RESEARCHER, PABLO AGUIAR, TALKS ABOUT THE EUROPEAN PROJECT neuroATLANTIC, PRESENTED AT THE IV FORUM RIES19THE GALICIAN RESEARCHER, PABLO AGUIAR, TALKS ABOUT THE EUROPEAN PROJECT neuroATLANTIC, PRESENTED AT THE IV FORUM RIES19
    12/05/2020
    The Galician researcher Pablo Aguiar has been […]
  • THE MAYOR OF THE CITY OF A CORUÑA HAS VALUED THE WORK OF THE CSG DURING THE INAUGURATION OF THE IV FORUM RIES2019 WHERE THE neuroATLANTIC PROJECT WAS PRESENTEDTHE MAYOR OF THE CITY OF A CORUÑA HAS VALUED THE WORK OF THE GALICIAN HEALTH CLUSTER (CSG) DURING THE INAUGURATION OF THE IV FORUM RIES2019 WHERE THE neuroATLANTIC PROJECT WAS PRESENTED
    12/05/2020
    The mayor of A Coruña was in charge of inaugurating […]
  • IDIS IS LEADING A EUROPEAN RESEARCH PROJECT THE DIAGNOSIS TREATMENT PREVALENT NEUROLOGICAL DISEASES ASSOCIATED AGINGTHE SANTIAGO DE COMPOSTELA HEALTH RESEARCH INSTITUTE (IDIS) IS LEADING A EUROPEAN RESEARCH PROJECT ON THE DIAGNOSIS AND TREATMENT OF PREVALENT NEUROLOGICAL DISEASES ASSOCIATED WITH AGING
    12/05/2020
    As reported by Compostela health management in a […]
  • SANTIAGO RESEARCHERS LEAD A EUROPEAN PROJECT TO STOP STROKES AND ALZHEIMER DISEASESSANTIAGO RESEARCHERS LEAD A EUROPEAN PROJECT TO STOP STROKES AND ALZHEIMER DISEASES.
    12/05/2020
    The Santiago Health Research Institute (Instituto de […]
  • FIDIS LEADS THE NEUROATLANTIC PROJECT ON DIAGNOSIS AND TREATMENT OF NEUROLOGICAL DISEASESFIDIS LEADS THE NEUROATLANTIC PROJECT ON DIAGNOSIS AND TREATMENT OF NEUROLOGICAL DISEASES
    12/05/2020
    The laboratories of Fundación Instituto de […]
<< Apr 2021 >>
MTWTFSS
29 30 31 1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 1 2
Tweets by ClusterSaude
Leading Partner
Fundación Instituto de Investigación Sanitaria de Santiago de Compostela (FIDIS)

Fundación Instituto de Investigación Sanitaria de Santiago de Compostela (FIDIS)

Partners

Center for Cooperative Research in Biomaterials CICbiomaGUNE

Center for Cooperative Research in Biomaterials CICbiomaGUNE

Clúster Saúde de Galicia – CSG

Clúster Saúde de Galicia – CSG

Institut National de la Santé et de la Recherche Médicale (INSERM) Délégation Régionale Nord Ouest

Institut National de la Santé et de la Recherche Médicale (INSERM) Délégation Régionale Nord Ouest

LINCBIOTECH, SL

LINCBIOTECH, SL

QUBIOTECH HEALTH INTELLIGENCE SL

QUBIOTECH HEALTH INTELLIGENCE SL

STAB VIDA Investigaçao e Serviços em Ciencias Biológicas, Lda

STAB VIDA Investigaçao e Serviços em Ciencias Biológicas, Lda

Universidade de Coimbra Divisao de Apoio e Promoçao da Investigaçao

Universidade de Coimbra Divisao de Apoio e Promoçao da Investigaçao

University College Cork – National University of Ireland Office of the VicePresident for Research & Innovation

University College Cork – National University of Ireland Office of the VicePresident for Research & Innovation

Our location

Contact Form

neuroATLANTIC

Fundación Instituto de Investigación Sanitaria de Santiago de Compostela
Hospital Clínico, Edificio D, 1º Andar
Travesa da Choupana s/n. 15706 Santiago de Compostela
+34 981 950 418
contact@neuroatlantic.eu
idisantiago.es

Esta web utiliza cookies, puedes ver aquí la Política de Cookies